Columbus Circle Investors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Columbus Circle Investors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-688,274	Closed	-$5.69M	–	331
2015 Q2	$5.69M	Sell	688,274 -275,733	-29%	-$2.44M	0.04%	234
2015 Q1	$7.94M	Sell	964,007 -934,137	-49%	-$6.91M	0.05%	219
2014 Q4	$13M	Sell	1,898,144 -428,272	-18%	-$2.68M	0.09%	186
2014 Q3	$12.6M	Buy	+2,326,416	New	+$13.6M	0.09%	182
2013 Q4	–	Sell	-341,756	Closed	-$6.29M	–	362
2013 Q3	$6.29M	Sell	341,756 -1,377,581	-80%	-$26.7M	0.04%	242
2013 Q2	$30.1M	Buy	+1,719,337	New	+$30.5M	0.24%	115

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbus Circle Investors's ARIA Position: Q3 2015 in Review

Columbus Circle Investors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 688,274 shares — an estimated $5.69M sold.

Columbus Circle Investors first reported a position in ARIA in Q2 2013 and held it in 6 quarters. The position peaked at $30.1M in Q2 2013. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

Columbus Circle Investors reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Columbus Circle Investors sold 688,274 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $5.69M.
Columbus Circle Investors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 6 quarters.
Columbus Circle Investors's Ariad Pharmaceuticals Inc position peaked at $30.1M in Q2 2013.
175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on Columbus Circle Investors's 13F filing for Q3 2015, filed 2 Nov 2015.